December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Highlights of the RADIOSA phase II trial presented at ESTRO24
Jul 5, 2024, 01:49

Highlights of the RADIOSA phase II trial presented at ESTRO24

European Society for Radiotherapy and Oncology (ESTRO) shared a paper on LinkedIn:

“Highlights of the RADIOSA phase II trial presented at ESTRO24: SBRT + short-term ADT significantly improves outcomes in oligorecurrent hormone-sensitive prostate cancer patients.

Report by Simon Spohn.”

Read further.
Source: ESTRO/LinkedIn

.